Dr. Shruti Kate

Consultant - Medical Oncology

Home / Our Doctors / Dr. Shruti Kate

Consultant - Medical Oncology

Book Appointment

Consultant - Medical Oncology

Qualification

MBBS, MD (Internal Medicine), DM (Medical Oncology)

Experience

15 Year

Specialities

Email

with Dr. Shruti Kate

Dr. Shruti’s key areas of interest include gynaecological cancers, genitourinary cancers, thoracic cancers, gastrointestinal cancers and haematological malignancies.
She has 7 years of experience and is experienced in treating all solid tumours, paediatric tumours, and haematological malignancies.
Dr. Shruti has a special interest in immunotherapy and metronomic therapy for the treatment of advanced cancers.
She has handled more than 50,000 cases so far.

She is a member of several reputed national & international oncological societies, such as ASCO, ESMO, IASLC, ISMPO, and IOS.
She has presented her research on lung cancer in the World Conference on Lung Cancer (WCLC) in Toronto, Canada, and was the sole recipient of a travel award from India in WCLC 2018.

Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis. Lung Cancer (Auckl). 2019 Jan 29;10:1-10.
Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia – A single center prospective study. Cancer Treat Res Commun. 2021;26:100280.
Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience. Eur J Breast Health. 2020 Dec 24;17(1):62-67.
A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies. J Pediatr Hematol Oncol. 2020 May;42(4):e202-e206.
Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study. Ecancermedicalscience. 2018 Oct 9;12:876.